Daniel M. Jorgensen
Chief Tech/Sci/R&D Officer at Ocugen OpCo, Inc.
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Kelly Beck | F | 48 |
Ocugen OpCo, Inc.
| 7 years |
Ramesh Kumar | M | 68 |
Ocugen OpCo, Inc.
| 5 years |
Frank Leo | M | 68 |
Ocugen OpCo, Inc.
| 7 years |
Shankar Musunuri | M | 60 |
Ocugen OpCo, Inc.
| 11 years |
Suha Halit Taspolatoglu | M | 62 |
Ocugen OpCo, Inc.
| 7 years |
Manish Potti | M | 38 |
Ocugen OpCo, Inc.
| 8 years |
Junge Zhang | M | 57 |
Ocugen OpCo, Inc.
| 9 years |
Prabhavathi Fernandes | M | 74 | 4 years | |
Vijay Tammara | M | 64 |
Ocugen OpCo, Inc.
| 7 years |
Uday Kompella | M | 57 |
Ocugen OpCo, Inc.
| 11 years |
Kirsten Castillo | F | 51 | 4 years | |
Klaus Romero | M | - |
Critical Path Institute
Critical Path Institute Miscellaneous Commercial ServicesCommercial Services Critical Path Institute is a nonprofit organization established in 2005 as a public and private partnership with the FDA's Critical Path Initiative program. The non-profit company is based in Tucson, AZ, and operates from Ireland with additional staff in multiple other locations. The company's mission is to catalyze the development of new approaches that advance medical innovation and regulatory science, accelerating the path to a healthier world. The company orchestrates the development of drug development tools through an innovative, collaborative approach to the sharing of data and expertise, and accelerate the pace and reduce the costs of medical product development by building consensus among the participating institutions. The company was founded in 2005 by Raymond L. Woosley, Glenn C. Rice. Daniel M. Jorgensen has been the CEO of the company since 2022. | - |
Rasappa Arumugham | M | 73 |
Ocugen OpCo, Inc.
| 7 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Sanjay Subramanian | M | 48 | 3 years | |
Jessica Crespo | F | 47 | 4 years | |
Mark Tobin | M | 50 | 3 years | |
Zorik Spektor | M | 67 | 9 years | |
Joseph Lobacki | M | 65 |
Finch Research & Development LLC
Finch Research & Development LLC Pharmaceuticals: MajorHealth Technology Part of Finch Therapeutics Group, Inc., Finch Research & Development LLC provides biopharmaceutical services. The company is based in Cambridge, MA. Finch Research & Development was acquired by Finch Therapeutics, Inc. on October 23, 2017. | 1 years |
William James Alexander | M | 74 | 1 years | |
Sun Altbach | F | - |
Finch Research & Development LLC
Finch Research & Development LLC Pharmaceuticals: MajorHealth Technology Part of Finch Therapeutics Group, Inc., Finch Research & Development LLC provides biopharmaceutical services. The company is based in Cambridge, MA. Finch Research & Development was acquired by Finch Therapeutics, Inc. on October 23, 2017. | 1 years |
Susan Drexler | F | 54 | 1 years |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 21 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Daniel M. Jorgensen
- Personal Network